United States Medical Instruments & Supplies news

15:10 11 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

Microbot Medical Inc. (MBOT) reported a Q2 loss of $0.08 per share, in line with the Zacks Consensus Estimate, but missed revenue expectations with $0.24 million against an anticipated $0.31 million. Despite underperforming the market year-to-date, the company holds a Zacks Rank #2 (Buy), …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

15:05 11 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q2 CY2026, but sales fell by 4.1% year on year to $898 million. On the other hand, the company's full-year revenue guidance …

XRAY main company

Sharemaestro market context Price above Trend Line 52 weeks -10.1%

14:56 11 Aug 2026

Pluang Earnings Main company 🇺🇸 United States

Intuitive Surgical stock drops 30% YTD but shows strong growth and recurring revenue in surgical robotics.

Intuitive Surgical's stock has declined over 30% year-to-date, but the company demonstrates strong underlying growth, with its da Vinci system fleet expanding and recurring revenue now forming 85% of total revenue. The new da Vinci 5 platform is expected to drive long-term growth, and …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

14:41 11 Aug 2026

TradingView Earnings Main company 🇺🇸 United States

Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs

Alcon (ALC) reported stronger-than-expected Q2 2026 core earnings and revenues, leading to a 3.2% rise in its stock price. The company saw growth across its Surgical and Vision Care segments, driven by new product launches and price increases, despite some challenges in the implantables …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

14:40 11 Aug 2026

seekingalpha.com Market update Provider-linked mention 🇺🇸 United States

These stocks have some of Wall Street’s lowest short interest

[short sale] abluecup Stocks including Apple, Alphabet, Exxon Mobil, and JPMorgan are among the companies with relatively low short interest, according to a screen of stocks with market capitalizations above $2B. The screen includes stocks with short interest between 1% and 2% of shares …

BLCO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +15.3%

14:10 11 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Microbot Medical (NASDAQ: MBOT) posts first LIBERTY sales with $67M in cash

Microbot Medical (NASDAQ: MBOT) has reported its first commercial revenue from the LIBERTY® Endovascular Robotic System, totaling $241,000 in Q2 2026 and $346,000 for the first half of 2026. Despite these initial sales, the company incurred a net loss of $5.6 million for the …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

14:10 11 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Microbot Medical's LIBERTY System Gets Marketing Clearance in Israel

Microbot Medical (NASDAQ: MBOT) reported over 100% revenue and customer growth in Q2 2026, driven by the successful Full Market Release of its LIBERTY endovascular robotic system. The company expanded its U.S. sales territories, partnered for access to federal healthcare facilities, and received marketing …

MBOT main company

Sharemaestro market context Price below Trend Line 52 weeks -38.8% · Next-week setup negative 40.3%

14:09 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue …

ISRG mentioned

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

13:40 11 Aug 2026

MarketBeat Analyst action Main company 🇺🇸 United States

Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating from BTIG Research

BTIG Research has reaffirmed its "Buy" rating for Merit Medical Systems (NASDAQ:MMSI), setting a price target of $105, which suggests a 17% upside. The company recently surpassed earnings estimates with an EPS of $1.19 and saw its revenue increase by 9.5% year-over-year to $418.84 …

MMSI main company

Sharemaestro market context Price above Trend Line 52 weeks +4.1%

13:11 11 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

Harvard Bioscience beats estimates, raises 2026 guidance

Harvard Bioscience Inc. (NASDAQ:HBIO) surpassed analyst expectations for its second-quarter 2026 results, reporting adjusted EPS of -$0.14 and revenue of $22.7 million, exceeding estimates. The company also raised its full-year 2026 revenue guidance to 3%-5% YoY growth, citing strong demand for its telemetry and …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup negative 40.6%

12:54 11 Aug 2026

Investing.com Canada Market update Main company 🇺🇸 United States

Form 8K BAXTER INTERNATIONAL INC For: 11 August By Investing.com

Investing.com reported the filing of a Form 8K by Baxter International Inc. on August 11. The article provides the title of the filing and indicates it pertains to Baxter International, a company whose stock is tracked on financial markets.

BAX main company

Sharemaestro market context Trend signal active 52 weeks +14.9% · Next-week setup negative 42.6%

12:41 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇺🇸 United States

Earnings Nudge European Bourses Higher Midday

European bourses tracked modestly higher midday Tuesday as traders weighed corporate earnings result PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? …

ALC mentioned

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

12:37 11 Aug 2026

Market source Earnings Provider-linked mention 🇺🇸 United States

Cardinal Health (CAH) Q4 Earnings Beat Estimates

Cardinal Health (CAH) reported Q4 earnings of $2.91 per share, surpassing the Zacks Consensus Estimate of $2.42, marking a 20.25% surprise. While earnings beat expectations, the company's revenues of $63.67 billion missed the consensus estimate

COO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +1.3%

12:37 11 Aug 2026

Investing.com Market update Main company 🇺🇸 United States

Baxter International interim CFO Anita Zielinski to resign in September

Baxter International Inc. announced that Anita Zielinski, interim CFO, will resign effective September 15, 2026, to join another organization. The company stated her resignation is not due to any disagreements with management or the board. This information was disclosed in an SEC filing on …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +14.9% · Next-week setup negative 42.6%

12:25 11 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Alcon raises 2026 earnings growth outlook on positive Q2 results

Alcon has reported Q2 revenues of around $2.8bn, indicative of an 8% uptick year-over-year (YoY), prompting it to revise its 2026 outlook. The Swiss eyecare specialist now expects 2026 earnings growth to land in the 12% to 15% per diluted share range, up from …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

12:11 11 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Harvard Bioscience (HBIO) grows Q2 2026 sales but stays in loss

Harvard Bioscience (HBIO) reported an 11.1% increase in Q2 2026 revenue, reaching $22.7 million, with full-year revenue guidance raised to 3%-5% growth. Despite top-line expansion and improved gross margins, the company remains unprofitable, recording a Q2 2026 net loss of $2.9 million. Operating cash …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup negative 40.6%

12:10 11 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

ResMed CEO Michael Farrell sells $1.03m in company stock

Michael J. Farrell, CEO of ResMed Inc. (NYSE:RMD), sold 4,991 shares of company stock worth approximately $1.03 million on August 7, 2026, while also acquiring 4,991 shares through option exercise for $730,382. These transactions were executed under a Rule 10b5-1 trading plan. ResMed recently …

RMD main company

Sharemaestro market context Price below Trend Line 52 weeks -25.0%

12:09 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Insider Selling: ResMed (NYSE:RMD) CEO Sells $1,026,598.79 in Stock

ResMed CEO Michael Farrell sold 4,991 shares of company stock worth approximately $1.03 million under a pre-arranged trading plan, reducing his stake by 1.06%. Despite this insider selling, ResMed reported strong financial results, beating EPS estimates and increasing its quarterly dividend. The company also …

RMD main company

Sharemaestro market context Price below Trend Line 52 weeks -25.0%

12:08 11 Aug 2026

Quiver Quantitative Earnings Main company 🇺🇸 United States

Harvard Bioscience Q2 Revenue Rises 11 Percent to $22.7 Million

Harvard Bioscience (HBIO) reported an 11% increase in Q2 2026 revenue, reaching $22.7 million, despite a GAAP net loss of $2.9 million. The company also raised its full-year 2026 revenue guidance to 3% to 5% growth. Insider trading data shows multiple purchases of HBIO …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup negative 40.6%

11:39 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Handelsbanken Fonder AB Decreases Stock Position in Intuitive Surgical, Inc. $ISRG

Handelsbanken Fonder AB reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.9% in the second quarter, selling over 31,000 shares but still retaining a significant holding valued at $127.2 million. Despite this decrease, Intuitive Surgical reported strong quarterly earnings, beating analyst estimates with …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

10:49 11 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

ICUI Q2 Deep Dive: Margin Expansion and Infusion Systems Drive Outperformance

ICUI Q2 Deep Dive: Margin Expansion and Infusion Systems Drive Outperformance Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street's revenue expectations , but sales were flat year on year at $547.9 million. Its non-GAAP profit of $2.37 per share …

ICUI main company

Sharemaestro market context Trend signal active 52 weeks +52.6%

10:43 11 Aug 2026

Simply Wall Street Earnings Main company 🇺🇸 United States

Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue Outlook - Has The Bull Case Changed?

Azenta (AZTA) reported a strong third quarter in 2026, returning to profitability with US$2.46 million in net income and US$161.18 million in revenue, while also raising its full-year revenue guidance to US$613-US$618 million. The company completed a US$50 million share repurchase, which, combined with …

AZTA main company

Sharemaestro market context Price above Trend Line 52 weeks +5.4%

10:41 11 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was …

SOLV main company

Sharemaestro market context Trend signal active 52 weeks +16.2% · Next-week setup negative 39.1%

10:13 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

99,902 Shares in AptarGroup, Inc. $ATR Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. has acquired 99,902 shares of AptarGroup, Inc. (NYSE:ATR) worth approximately $12.5 million, marking a new stake in the company. AptarGroup also reported strong quarterly earnings, exceeding expectations with $1.42 EPS and $1.03 billion in revenue, and declared a quarterly dividend …

ATR main company

Sharemaestro market context Price above Trend Line 52 weeks -1.3%

10:03 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

NewEdge Advisors LLC Acquires 11,414 Shares of Becton, Dickinson and Company $BDX

NewEdge Advisors LLC significantly increased its stake in Becton, Dickinson and Company (NYSE:BDX) by 35% in the first quarter, adding 11,414 shares to reach a total of 44,032 shares valued at approximately $6.9 million. The company reported strong quarterly earnings, surpassing expectations with $3.23 …

BDX main company

Sharemaestro market context Price above Trend Line 52 weeks +17.6% · Next-week setup negative 32.1%

10:03 11 Aug 2026

GuruFocus Earnings Main company 🇺🇸 United States

Bausch & Lomb Corp (BLCO) Director Andrew C. von Eschenbach Sells 18,559 Shares

Bausch & Lomb Corp (BLCO) Director Andrew C. von Eschenbach sold 18,559 shares for approximately $306,780, reducing his direct ownership to 63,733 shares. Despite this sale, GuruFocus's valuation model suggests the stock is modestly undervalued, and broader insider activity shows significantly more buying than …

BLCO main company

Sharemaestro market context Price above Trend Line 52 weeks +15.3%

09:42 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Defender Capital LLC. Has $12.37 Million Position in STAAR Surgical Company $STAA

Defender Capital LLC. reduced its stake in STAAR Surgical Company (NASDAQ:STAA) by 33.1% in the second quarter, now holding 431,187 shares valued at $12.37 million, which represents 4% of its portfolio. STAAR Surgical reported strong Q2 earnings, beating analyst expectations with EPS of $0.10 …

STAA main company

Sharemaestro market context Trend signal active 52 weeks -14.7% · Next-week setup negative 43.8%

09:31 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

E. Ohman J or Asset Management AB Grows Position in Intuitive Surgical, Inc. $ISRG

E. Ohman J or Asset Management AB has increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.7% in the second quarter, bringing its total holdings to 26,069 shares valued at $10.37 million. Other institutional investors also adjusted their positions in the medical equipment …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

09:25 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Defender Capital LLC. Purchases 8,833 Shares of Intuitive Surgical, Inc. $ISRG

Defender Capital LLC significantly increased its stake in Intuitive Surgical, Inc. by 1,386.7% in the second quarter, bringing its total holdings to 9,470 shares valued at $3.77 million. This comes as Intuitive Surgical reported strong quarterly earnings of $2.80 per share and revenue of …

ISRG main company

Sharemaestro market context Price below Trend Line 52 weeks -21.1% · Next-week setup negative 40.2%

08:30 11 Aug 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Alcon rises on profit guidance hike, lowered tariff impact estimate

Investing.com -- Alcon lifted its full-year profit guidance late Monday and lowered its estimate for the annual tariff impact to $40 million to $90 million, from a prior range of $100 million to $150 million, factoring in an anticipated refund of around $60 million …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

08:27 11 Aug 2026

MarketBeat Analyst action Main company 🇺🇸 United States

Assenagon Asset Management S.A. Grows Stock Holdings in ResMed Inc. $RMD

Assenagon Asset Management S.A. significantly increased its stake in ResMed Inc. by 48.2% in the second quarter, now owning 83,852 shares valued at $16.34 million. This move is part of a broader trend of institutional investors adjusting their positions in ResMed, with hedge funds …

RMD main company

Sharemaestro market context Price below Trend Line 52 weeks -25.0%

08:10 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Assenagon Asset Management S.A. Has $23.25 Million Position in West Pharmaceutical Services, Inc. $WST

Assenagon Asset Management S.A. significantly reduced its stake in West Pharmaceutical Services (NYSE:WST) by 52.9% in Q2, retaining 64,754 shares valued at $23.25 million. Despite this, institutional investors own 93.9% of the company, and analysts maintain a consensus "Buy" rating with an average price …

WST main company

Sharemaestro market context Trend signal active 52 weeks +44.2%

08:09 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month High - Time to Buy?

BioLife Solutions (NASDAQ:BLFS) recently hit a new 52-week high of $34.93, trading nearly flat at $34.64. The company reported strong quarterly earnings of $0.91 per share, significantly beating the consensus estimate of $0.03, and revenue of $28.47 million, exceeding expectations. Despite insider selling activity …

BLFS main company

Sharemaestro market context Trend signal active 52 weeks +42.4%

08:00 11 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Harvard Bioscience Lifts 2026 Revenue Outlook After 11% Q2 Growth

Harvard Bioscience (HBIO) reported an 11% year-over-year revenue increase to $22.7 million in Q2 2026, leading them to raise their full-year 2026 revenue growth guidance to 3-5%. Despite a widened GAAP net loss, adjusted EBITDA saw growth, and the company provided Q3 2026 revenue …

HBIO main company

Sharemaestro market context Trend signal active 52 weeks +22.3% · Next-week setup negative 40.6%

07:41 11 Aug 2026

1470 & 100.3 WMBD Guidance Main company 🇺🇸 United States

Eye care company Alcon raises profitability outlook, cuts tariff hit estimate

Alcon, a Swiss-American eye care company, raised its 2026 profitability target and its guidance for core diluted earnings per share, leading to a 4% jump in shares. This increase was driven by improved margin performance in its Equipment and Ocular Health divisions and a …

ALC main company

Sharemaestro market context Price below Trend Line 52 weeks -17.2% · Next-week setup positive 55.9%

07:35 11 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Reduce" by Analysts

Thirteen research firms have given Baxter International Inc. (NYSE:BAX) an average rating of "Reduce," with a collective price target of $22.45, below its current trading price of $27.84. Despite this cautious outlook, Baxter International reported strong quarterly results, exceeding analyst expectations with an adjusted …

BAX main company

Sharemaestro market context Trend signal active 52 weeks +14.9% · Next-week setup negative 42.6%